title: Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons.
authors.forename: Frank
authors.initials: F
authors.lastname: Martiniuk
authors.forename: Shaline D
authors.initials: SD
authors.lastname: Rao
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Rea
authors.forename: Michael S
authors.initials: MS
authors.lastname: Glickman
authors.forename: Jerome
authors.initials: J
authors.lastname: Giovinazzo
authors.forename: William N
authors.initials: WN
authors.lastname: Rom
authors.forename: Aloys
authors.initials: A
authors.lastname: Cabrera
authors.forename: William R
authors.initials: WR
authors.lastname: Levis
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D003622:Dapsone / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000150:complications*; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000150:complications*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D007917:Leprostatic Agents; D003622:Dapsone; D012293:Rifampin